Valuation : Becton, Dickinson and Company

Market Cap 51.62B 44.48B 41.71B 38.07B 71.72B 4,934B 71.95B 495B 193B 2,491B 194B 190B 8,258B P/E 2026 *
36.5x
P/E 2027 * 20.4x
Enterprise Value 67.51B 58.17B 54.54B 49.79B 93.79B 6,452B 94.09B 647B 252B 3,257B 253B 248B 10,799B EV / Sales 2026 *
3.5x
EV / Sales 2027 * 3.32x
Free-Float
73.18%
Yield 2026 *
2.07%
Yield 2027 * 2.11%
1 day+0.74%
1 week-1.29%
Current month+14.43%
1 month+13.94%
3 months+27.70%
6 months+7.39%
Current year-2.34%
1 week 187.03
Extreme 187.03
193.07
1 month 162.45
Extreme 162.45
193.07
Current year 140.11
Extreme 140.11
213.08
1 year 140.11
Extreme 140.11
213.08
3 years 140.11
Extreme 140.11
283.5
5 years 140.11
Extreme 140.11
287.32
10 years 140.11
Extreme 140.11
287.32
Manager TitleAgeSince
Chief Executive Officer 53 27/01/2020
Director of Finance/CFO 44 04/12/2025
Compliance Officer - 31/01/2023
Director TitleAgeSince
Director/Board Member 75 23/09/2002
Director/Board Member 71 25/07/2010
Chairman 53 27/04/2021
Date Insider Type Main position Quantity % Market Cap.
26/08/26 Sell

Executive/Senior Manager

-165 0.0001%
20/08/26 Tax

Executive/Senior Manager

-1,049 0.0004%
13/08/26 Fiscal year

Chief Executive Officer

129,834 0.0471%
Change 5-day change 1-year change 3-year change Capi.($)
+0.74%-1.29%-0.90%-32.69% 51.62B
+0.79%-3.58%-14.39%+9.42% 195B
+1.40%-2.27%-0.79%+12.09% 117B
+0.25%+1.25%+11.09%+78.52% 61.45B
-0.25%-1.97%+26.78%+53.11% 51.03B
+1.71%-1.65%+20.96%-8.53% 34.27B
+1.82%+2.98% - - 30.95B
-2.49%-4.42%+37.49%-16.34% 23.75B
-0.82%-1.17%-4.66%+18.23% 23.41B
+0.35%-1.74%-4.49%+2.61% 22.79B
Average +0.35%-1.10%+7.90%+12.94% 61.07B
Weighted average by Cap. +0.66%-1.84%+0.87%+15.35%

Financials

2026 *2027 *
Net sales 19.29B 16.62B 15.59B 14.23B 26.8B 1,844B 26.89B 185B 72.15B 931B 72.43B 70.85B 3,086B 19.73B 17B 15.94B 14.55B 27.42B 1,886B 27.5B 189B 73.8B 952B 74.09B 72.47B 3,157B
Net income 1.44B 1.24B 1.16B 1.06B 2B 137B 2B 13.77B 5.37B 69.31B 5.39B 5.28B 230B 2.34B 2.02B 1.89B 1.73B 3.25B 224B 3.26B 22.43B 8.75B 113B 8.78B 8.59B 374B
Net Debt 15.88B 13.69B 12.83B 11.72B 22.07B 1,518B 22.14B 152B 59.41B 766B 59.64B 58.34B 2,541B 13.95B 12.02B 11.27B 10.29B 19.38B 1,333B 19.45B 134B 52.18B 673B 52.38B 51.24B 2,232B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
28/08/26 US$189.52 +0.74% 1,693,786
27/08/26 US$188.13 -1.09% 1,354,083
26/08/26 US$190.21 +0.23% 1,403,112
25/08/26 US$189.78 -0.50% 1,207,516
24/08/26 US$190.74 -0.66% 1,310,993
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
189.52USD
Average target price
194.42USD
Spread / Average Target
+2.58%

Quarterly revenue - Rate of surprise